Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
- University of British Columbia
- RMIT University
- ;
- University of Oslo
- ; University of Warwick
- Academic Europe
- Curtin University
- Heidelberg University Hospital
- Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- Karolinska Institutet
- Leibniz
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Munich
- University Medical Centre Groningen (UMCG)
- University of Basel
- Université de Caen Normandie
- 11 more »
- « less
-
Field
-
3 May 2024 Job Information Organisation/Company Heidelberg University Hospital Department Department of Surgery Research Field Medical sciences » Cancer research Researcher Profile First Stage Researcher (R1) Recognised Researcher (R2) Country Germany Application Deadline 30 May 2024 - 23:59...
-
at the Department of Biomedicine (“Cancer Immunology”) and PD Dr. Matter at the Department of Pathology are seeking a highly motivated PhD candidate with scientific interest in Cancer Immunology & Immunotherapy
-
. The Applied Immunology & Immunotherapy group is physically located at the Centre for Molecular Medicine, a translational medical centre, and the research focus is developing innovative ways to treat chronic
-
immunotherapies to fight diseases such as cancer. We are currently advertising a PhD position in this area (funded by an EPSRC DTP Studentship) in the Dept. of Chemistry at Warwick co-supervised by Dr Ann Dixon and
-
Helmholtz-Zentrum Dresden-Rossendorf - HZDR - Helmholtz Association | Dresden, Sachsen | Germany | about 2 months ago
employment. Starting date: 01.06.2024 Job description:PhD Student (f/m/d) Pre-clinical development and validation of Adapter-RevCAR‐T-cell-system for immunotherapy of melanoma With cutting-edge research in
-
to impressive therapeutic effects, immunotherapies tend to take an increasingly important place in the treatment of many cancers such as lung or skin cancers. Immunotherapy consists of creating or strengthening a
-
to study how the immune system can be harnessed to develop cancer immunotherapies. In particular, we are studying how oncolytic virotherapy can be used in synergy with immunotherapy to achieve optimal
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu ) is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy
-
biomarkers for precise disease monitoring. Furthermore, the unique glycan profiles of tumors provide appealing targets for cancer immunotherapy. This project seeks to exploit tumor-specific glycosylation
-
. As a PhD candidate you will focus on analyses of patient-related factors for outcome and chemotherapy and immunotherapy treatment response and toxicity in bladder cancer. The candidate will contribute